HPBT
BIO icon

High Point Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

High Point Bank & Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$24K Hold
130
– – 0.01% 280
2016
Q3 		$21K Hold
130
– – 0.01% 299
2016
Q2 		$19K Hold
130
– – 0.01% 292
2016
Q1 		$18K Buy
+130
New +$17.1K ﹤0.01% 304

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

High Point Bank & Trust's BIO Position: Q4 2016 in Review

High Point Bank & Trust held its Bio-Rad Laboratories Class A (BIO) position steady in Q4 2016 at 130 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #280.

High Point Bank & Trust first reported a position in BIO in Q1 2016 and has held it in 4 quarters since. 261 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

  • High Point Bank & Trust held 130 shares of Bio-Rad Laboratories Class A worth $24K as of Q4 2016.
  • High Point Bank & Trust left its Bio-Rad Laboratories Class A share count unchanged in Q4 2016.
  • Bio-Rad Laboratories Class A made up 0.01% of High Point Bank & Trust's portfolio in Q4 2016, its #280 holding.
  • High Point Bank & Trust first reported a position in Bio-Rad Laboratories Class A in Q1 2016 and has held it in 4 quarters since.
  • 261 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.